Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Jacob Alexander Sloane, M.D.

Co-Author

This page shows the publications co-authored by Jacob Sloane and Eric Klawiter.
Connection Strength

0.415
  1. Quantitative 7-Tesla Imaging of Cortical Myelin Changes in Early Multiple Sclerosis. Front Neurol. 2021; 12:714820.
    View in: PubMed
    Score: 0.058
  2. Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression. Brain Commun. 2021; 3(3):fcab134.
    View in: PubMed
    Score: 0.057
  3. The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI. J Neurol. 2021 Jul; 268(7):2473-2481.
    View in: PubMed
    Score: 0.056
  4. 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis. Brain. 2020 10 01; 143(10):2973-2987.
    View in: PubMed
    Score: 0.054
  5. Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRI. Mult Scler. 2021 04; 27(5):674-683.
    View in: PubMed
    Score: 0.053
  6. Profiles of cortical inflammation in multiple sclerosis by 11C-PBR28 MR-PET and 7 Tesla imaging. Mult Scler. 2020 10; 26(12):1497-1509.
    View in: PubMed
    Score: 0.050
  7. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis. Brain. 2017 Nov 01; 140(11):2912-2926.
    View in: PubMed
    Score: 0.045
  8. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol. 2016 Nov; 80(5):776-790.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.